Showing results (61-70 of 162) with videos related to

Sort By:
Pageof 17
Journal of Clinical Medicine|February 25, 2023
Data Resource Profile: The Multiple Sclerosis Documentation System 3D and AOK PLUS Linked Database (MSDS-AOK PLUS)Marco Ghiani, Evi Zhuleku, Anja Dillenseger, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Clinical and economic benefits of seasonal COVID-19 vaccination in Germany: results from the ROUTINE-COV19 Study, September 2022 to March 2024Andrea Schmetz, Julia Knaul, Sabrina Müller, et al.
Journal of Thrombosis and Thrombolysis|September 15, 2014
Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-useThomas Wilke, Antje Groth, Matthias Pfannkuche, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 6, 2021
Extent of non-adherence and non-persistence in asthma patients: analysis of a large claims data setFränce Hardtstock, Ulf Maywald, Hartmut Timmermann, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 21, 2012
How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitusThomas Wilke, Antje Groth, Sabrina Mueller, et al.
Respiratory Research|September 1, 2018
Primary data, claims data, and linked data in observational research: the case of COPD in GermanySabrina Mueller, Fraence Gottschalk, Antje Groth, et al.
The Science of the Total Environment|January 5, 2025
Increasing microplastic concentrations have nonlinear impacts on the physiology of reef-building coralsVanessa Tirpitz, Mona Hutter, Hanna Hutter, et al.
Archives of Osteoporosis|August 13, 2020
Estimated epidemiology of osteoporosis diagnoses and osteoporosis-related high fracture risk in Germany: a German claims data analysisPeyman Hadji, Fränce Hardtstock, Thomas Wilke, et al.
Pageof 17